These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 20166872)
1. The type I IFN system in rheumatoid arthritis. Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872 [TBL] [Abstract][Full Text] [Related]
2. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy. Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433 [TBL] [Abstract][Full Text] [Related]
3. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115 [TBL] [Abstract][Full Text] [Related]
4. Autoimmunity and bone. Schwarz EM; Looney RJ; Drissi MH; O'Keefe RJ; Boyce BF; Xing L; Ritchlin CT Ann N Y Acad Sci; 2006 Apr; 1068():275-83. PubMed ID: 16831928 [TBL] [Abstract][Full Text] [Related]
5. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427 [TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance? Lebre MC; Tak PP Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells and interferon-mediated autoimmunity. Gottenberg JE; Chiocchia G Biochimie; 2007; 89(6-7):856-71. PubMed ID: 17562353 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis. Wenink MH; Han W; Toes RE; Radstake TR Handb Exp Pharmacol; 2009; (188):81-98. PubMed ID: 19031022 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells from bench to bedside and back. Adema GJ Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337 [TBL] [Abstract][Full Text] [Related]
11. Tolerogenic dendritic cells for autoimmune disease and transplantation. Thomson AW; Robbins PD Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823 [TBL] [Abstract][Full Text] [Related]
12. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB. Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748 [TBL] [Abstract][Full Text] [Related]
13. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Popov I; Li M; Zheng X; San H; Zhang X; Ichim TE; Suzuki M; Feng B; Vladau C; Zhong R; Garcia B; Strejan G; Inman RD; Min WP Arthritis Res Ther; 2006; 8(5):R141. PubMed ID: 16911769 [TBL] [Abstract][Full Text] [Related]
14. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell subsets: their roles in rheumatoid arthritis. Lebre MC; Tak PP Acta Reumatol Port; 2008; 33(1):35-45. PubMed ID: 18344920 [TBL] [Abstract][Full Text] [Related]
16. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. Rizza P; Moretti F; Belardelli F Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707 [TBL] [Abstract][Full Text] [Related]
17. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971 [TBL] [Abstract][Full Text] [Related]
18. Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis. Takakubo Y; Takagi M; Maeda K; Tamaki Y; Sasaki A; Asano T; Fukushima S; Kiyoshige Y; Orui H; Ogino T; Yamakawa M J Rheumatol; 2008 Oct; 35(10):1919-31. PubMed ID: 18785315 [TBL] [Abstract][Full Text] [Related]
19. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. Douagi I; McInerney GM; Hidmark AS; Miriallis V; Johansen K; Svensson L; Karlsson Hedestam GB J Virol; 2007 Mar; 81(6):2758-68. PubMed ID: 17215281 [TBL] [Abstract][Full Text] [Related]
20. Type I interferon therapy and its role in autoimmunity. Biggioggero M; Gabbriellini L; Meroni PL Autoimmunity; 2010 Apr; 43(3):248-54. PubMed ID: 20298125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]